Lloyds Banking Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$56K Sell
615
-15
-2% -$1.52K 0.78% 32
2018
Q3
$69K Sell
630
-767
-55% -$79.9K 0.84% 35
2018
Q2
$130K Buy
+1,397
New +$120K 1.07% 41

Other funds holding PRAH

Lloyds Banking Group's PRAH Position: Q4 2018 in Review

Lloyds Banking Group reduced its PRA Health Sciences, Inc. (PRAH) stake by 2.4% in Q4 2018, selling an estimated $1.52K and leaving 615 shares worth $56K. The position accounts for 0.78% of the portfolio, ranked #32.

Lloyds Banking Group first reported a position in PRAH in Q2 2018 and has held it in 3 quarters since. The position peaked at $130K in Q2 2018. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

  • Lloyds Banking Group held 615 shares of PRA Health Sciences, Inc. worth $56K as of Q4 2018.
  • Lloyds Banking Group sold 15 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $1.52K.
  • PRA Health Sciences, Inc. made up 0.78% of Lloyds Banking Group's portfolio in Q4 2018, its #32 holding.
  • Lloyds Banking Group first reported a position in PRA Health Sciences, Inc. in Q2 2018 and has held it in 3 quarters since.
  • Lloyds Banking Group's PRA Health Sciences, Inc. position peaked at $130K in Q2 2018.
  • 334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on Lloyds Banking Group's 13F filing for Q4 2018, filed 11 Feb 2019.